The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

Zhittya Genesis Medicine proudly announces that Dr. Jack Jacobs, President and Chief Science Officer, will be honored by NevadaBio at its Annual Awards Dinner on Wednesday, April 2, 2025, at 5:30 pm ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to-severe Sjögren’s disease, which could be the first targeted therapy ever ...

Breakthrough T1D Canada is calling on the Quebec government to adopt the 2022 INESSS recommendation to eliminate current age restrictions on public coverage of insulin pumps and extend access to all ...

Exciting new research by Baker Heart and Diabetes Institute researchers raises the possibility that we could reduce the severity of heart failure and ...

Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side ...

Get unlimited access to breaking news, ancestry archives, our daily E-newspaper, games and more. Subscribe Today » ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.

Researchers have made a huge leap forward in the fight against Parkinson's disease, solving a decades-long mystery. In a major breakthrough, they have been able to see the human PINK1 protein and how ...

Research suggests that 40Hz gamma frequency stimulation may be beneficial for brain health and could potentially treat Alzheimer's disease, with positive outcomes observed in initial animal and human ...

Genetically targeted technologies are built on Nobel Prize-winning science. They represent a scientific “quantum leap” that ...